| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 2, 2004
Accepted on September 20, 2004
From First Department of Pathology (A.Y., K.M., K.H., A.S., Y.A.) and the Department of Radiology (E.F., S.T.), Miyazaki Medical College, University of Miyazaki, Miyazaki; Pharmaceutical Research Laboratories (H.Y.), Ajinomoto Co, Inc, Kawasaki; and the Department of Medicine (Hematology) (Y.I.), Keio University School of Medicine, Tokyo, Japan.
* To whom correspondence should be addressed. E-mail: yasada{at}fc.miyazaki-u.ac.jp.
Objective--Plaque disruption does not always result in complete thrombotic occlusion. The mechanism of arterial thrombus propagation remains unclear.
Methods and Results--We studied how vascular wall thrombogenicity and blood flow reduction affect thrombus propagation using a rabbit model of single and repeated balloon injury. After balloon injury of the normal femoral artery, the blood flow was reduced to 50%, 25%, or 10% (n=5). Small mural thrombi composed of aggregated platelets were produced, but no occlusive thrombi developed in any flow reduction. Three weeks after the first balloon injury, neointima with tissue factor expression and increased procoagulant activity was developed. Balloon injury of the neointima with the same blood flow reduction (n=5) induced fibrin-rich thrombus formation. Additionally, injury with flow reduced to 25% and 10% promoted thrombus propagation resulting in vessel occlusion within 160±18 and 71±17 seconds, respectively. An injection of anti-von Willebrand factor (vWF) monoclonal antibody (AJW200; 1.0 mg/kg) prevented occlusive thrombus formation.
Conclusions--Increased vascular wall thrombogenicity together with a substantial blood flow reduction is crucial for occlusive thrombus formation, and vWF plays an important role in thrombus propagation. Reduced blood flow at plaque disruption sites might contribute to thrombus propagation leading to acute coronary syndromes.
Related Article:
This article has been cited by other articles:
![]() |
Y. Takemoto, H. Kawata, T. Soeda, K. Imagawa, S. Somekawa, Y. Takeda, S. Uemura, M. Matsumoto, Y. Fujimura, J.-i. Jo, et al. Human Placental Ectonucleoside Triphosphate Diphosphohydrolase Gene Transfer via Gelatin-Coated Stents Prevents In-Stent Thrombosis Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 857 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishii, F. Vinuela, Y. Murayama, I. Yuki, Y.L. Nien, D.T. Yeh, and H.V. Vinters Swine model of carotid artery atherosclerosis: experimental induction by surgical partial ligation and dietary hypercholesterolemia. AJNR Am. J. Neuroradiol., October 1, 2006; 27(9): 1893 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goto Propagation of Arterial Thrombi: Local and Remote Contributory Factors Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2207 - 2208. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |